DPP1 Inhibitor Promising in Non-CF Bronchiectasis

(MedPage Today) -- Treatment with the investigational anti-inflammatory drug brensocatib (formerly INS1007) significantly delayed the time to exacerbation in patients with the rare lung disease non-cystic fibrosis bronchiectasis, researchers reported...